Wei Xue

1.7k total citations
72 papers, 1.2k citations indexed

About

Wei Xue is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Wei Xue has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 28 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Wei Xue's work include Renal cell carcinoma treatment (25 papers), Renal and related cancers (14 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Wei Xue is often cited by papers focused on Renal cell carcinoma treatment (25 papers), Renal and related cancers (14 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Wei Xue collaborates with scholars based in China, United States and United Kingdom. Wei Xue's co-authors include Jing‐An Rui, Haige Chen, Yong Huang, Ming Cao, Xianqing Huang, Qingyun Zhang, Junjian Liu, Genze Shao, Ye Zhang and Rouli Zhou and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Xue

65 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xue China 21 627 417 246 244 120 72 1.2k
Yan Shao China 20 358 0.6× 155 0.4× 201 0.8× 324 1.3× 297 2.5× 79 1.4k
Daniel W. Wilkey United States 19 749 1.2× 142 0.3× 236 1.0× 82 0.3× 79 0.7× 43 1.2k
Simona Ognjanovic United States 17 438 0.7× 497 1.2× 212 0.9× 79 0.3× 458 3.8× 33 1.6k
Hiroaki Yasumoto Japan 21 460 0.7× 367 0.9× 129 0.5× 285 1.2× 265 2.2× 63 1.2k
Alessia Pagani Italy 22 292 0.5× 205 0.5× 112 0.5× 56 0.2× 113 0.9× 58 2.4k
Jason Yongsheng Chan Singapore 19 500 0.8× 213 0.5× 184 0.7× 129 0.5× 403 3.4× 107 1.2k
Kim De Ruyck Belgium 21 585 0.9× 523 1.3× 364 1.5× 128 0.5× 246 2.0× 42 1.4k
Shiyu Xiao China 15 219 0.3× 138 0.3× 112 0.5× 214 0.9× 192 1.6× 33 846
Verena Broecker Germany 17 309 0.5× 153 0.4× 100 0.4× 331 1.4× 160 1.3× 32 1.2k
Sebastian Hinz Germany 17 408 0.7× 189 0.5× 268 1.1× 231 0.9× 568 4.7× 41 1.3k

Countries citing papers authored by Wei Xue

Since Specialization
Citations

This map shows the geographic impact of Wei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xue more than expected).

Fields of papers citing papers by Wei Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xue. The network helps show where Wei Xue may publish in the future.

Co-authorship network of co-authors of Wei Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xue. A scholar is included among the top collaborators of Wei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xue. Wei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Jianhui, Jingcheng Zhou, Lin Cai, et al.. (2025). Belzutifan monotherapy in Chinese patients (pts) with von Hippel-Lindau (VHL) disease–associated tumors: Results of LITESPARK-015 study.. Journal of Clinical Oncology. 43(5_suppl). 534–534. 3 indexed citations
2.
Pan, Rui, Xiaotong Wang, Ru Fang, et al.. (2025). GPNMB expression differentiates subependymal giant cell astrocytoma from other mimickers. Annals of Diagnostic Pathology. 75. 152442–152442. 1 indexed citations
3.
Zheng, Qingyun, Xiaoqiang Zhai, Zhen Su, et al.. (2025). Structure‐Guided Development of Chemically Tailored Peptide Binders of RNF43/ZNRF3 to Enable Versatile Design of Membrane Protein‐Targeting PROTACs. Angewandte Chemie International Edition. 64(19). e202501488–e202501488. 3 indexed citations
4.
Zhang, Ruiyun, Di Jin, Wei Xue, et al.. (2024). Real-world study of urine-based NGS liquid biopsy in organ preservation therapy of muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 42(16_suppl). e16602–e16602. 1 indexed citations
5.
Song, Qixiang, Sylvia O. Suadicani, Hiromitsu Negoro, et al.. (2024). Disruption of circadian rhythm as a potential pathogenesis of nocturia. Nature Reviews Urology. 22(5). 276–293. 5 indexed citations
6.
Li, Zijian, et al.. (2024). Novel curcumin derivatives N17 exert anti-cancer effects through the CSNK1G3/AKT axis in triple-negative breast cancer. Biochemical Pharmacology. 229. 116472–116472. 2 indexed citations
7.
Huang, Jiwei, Cuijian Zhang, Yige Bao, et al.. (2023). Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy. Urologic Oncology Seminars and Original Investigations. 41(10). 434.e17–434.e25. 3 indexed citations
8.
9.
Sun, Zhihong, et al.. (2023). Effect of different disinfectants on preventing asymptomatic bacteriuria and catheter-related urinary tract infection: a network meta-analysis. SHILAP Revista de lepidopterología. 3. 1173885–1173885. 1 indexed citations
10.
Wu, Xiaorong, Jiale Zhou, Wei Cai, et al.. (2023). Retroperitoneoscopic Clampless, Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors. Annals of Surgical Oncology. 31(1). 681–687. 1 indexed citations
11.
Huang, Jiwei, Xiaoying Yao, Jin Zhang, et al.. (2022). Cognitive Function After Cardiopulmonary Bypass and Deep Hypothermic Circulatory Arrest in Management of Renal Cell Carcinoma With Vena Caval Thrombus. Urology. 167. 144–151. 2 indexed citations
12.
Wu, Xiaorong, Chao Shen, Guangyu Wu, et al.. (2020). Three-dimensional reconstruction facilitates off-clamp laparoscopic partial nephrectomy for stage cT1b renal tumors. Translational Cancer Research. 9(3). 1528–1535. 2 indexed citations
13.
Gao, Wenwen, et al.. (2019). STAG2 loss-of-function mutation induces PD-L1 expression in U2OS cells. Annals of Translational Medicine. 7(7). 127–127. 15 indexed citations
14.
Wu, Xiaorong, Wei Chen, Yonghui Chen, et al.. (2016). Comparison of laparoscopic microwave ablation and radio frequency ablation assisted renal tumor enucleation for renal tumor smaller than 4 cm. Zhonghua miniao waike zazhi. 37(1). 12–16. 1 indexed citations
15.
Chen, Xiao, Xuan Wang, Wei Xue, & Jiandong Wang. (2016). EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma. Journal of Ovarian Research. 9(1). 83–83. 21 indexed citations
16.
Huang, Jiwei, Wen Kong, Yonghui Chen, et al.. (2013). Risk factors and clinical management of hemorrhage after open partial nephrectomy. Zhonghua miniao waike zazhi. 34(9). 649–652. 1 indexed citations
17.
Cao, Ming, Xin Mu, Chen Chen Jiang, et al.. (2013). Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis. Tumor Biology. 35(1). 759–764. 37 indexed citations
18.
Cai, Hui, et al.. (2013). Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Medical Oncology. 30(1). 452–452. 85 indexed citations
19.
20.
Zhou, Li, Jing‐An Rui, Shuguang Chen, et al.. (2007). Factors predictive for long‐term survival of male patients with hepatocellular carcinoma after curative resection. Journal of Surgical Oncology. 95(4). 298–303. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Shao Breakdown of academic impact, for papers by Daniel W. Wilkey Breakdown of academic impact, for papers by Simona Ognjanovic Breakdown of academic impact, for papers by Hiroaki Yasumoto Breakdown of academic impact, for papers by Alessia Pagani Breakdown of academic impact, for papers by Jason Yongsheng Chan Breakdown of academic impact, for papers by Kim De Ruyck Breakdown of academic impact, for papers by Shiyu Xiao Breakdown of academic impact, for papers by Verena Broecker Breakdown of academic impact, for papers by Sebastian Hinz
Rankless by CCL
2026